(BMTI) Community Analysis from
Bulls REASONS TO BUY
Bears REASONS TO SELL
May 21, 2013
(Benzinga,
11/4/10)
JP Morgan has published a research report on BioMimetic Therapeutics (NASDAQ: BMTI) as the company prepares for 2011 after reporting 3Q results last night after market close.
In the report, JP Morgan writes "The company is optimistic...(read more)
(Benzinga,
11/3/10)
BioMimetic Therapeutics, Inc. (NASDAQ: BMTI) today reported its financial results as of and for the three and nine months ended September 30, 2010. For the three months ended September 30, 2010, the Company reported a net loss of $7.8...(read more)
BioMimetic Therapeutics (BMTI) Company Overview
There is no analysis for BMTI yet. But you can go to Wikinvest to help create one!
